title: Lymphocyte abnormalities in patients with macro- and micro-prolactinoma: different effects of bromocriptine treatment in the two groups.
authors.affiliation: Institute of Internal Medicine, Infectious Diseases and Immunopathology, University of Milan, Italy.
authors.forename: B
authors.initials: B
authors.lastname: De Bernardi
authors.forename: R
authors.initials: R
authors.lastname: Scorza
authors.forename: C
authors.initials: C
authors.lastname: Hu
authors.forename: P
authors.initials: P
authors.lastname: Travaglini
authors.forename: O
authors.initials: O
authors.lastname: Della Casa Alberighi
authors.forename: M E
authors.initials: ME
authors.lastname: Togni
authors.forename: C
authors.initials: C
authors.lastname: Honorati
authors.forename: A
authors.initials: A
authors.lastname: Cigognini
mesh_terms: D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000032:analysis*; D001971:Bromocriptine / Q000627:therapeutic use*; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D010911:Pituitary Neoplasms / Q000097:blood / Q000145:classification / Q000188:drug therapy / Q000276:immunology*; D011388:Prolactin / Q000097:blood; D015175:Prolactinoma / Q000097:blood / Q000145:classification / Q000188:drug therapy / Q000276:immunology*; D012016:Reference Values
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D006684:HLA-DR Antigens; D001971:Bromocriptine; D011388:Prolactin